World Pharma News Digest - 19.05.2014
7 views
Skip to first unread message
Ruslan David
May 19, 2014, 6:43:12 AM5/19/14
to worldph...@googlegroups.com
AstraZeneca rejects final proposal from Pfizer
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.
Read more...
http://www.worldpharmanews.com/financial/2778-astrazeneca-rejects-final-proposal-from-pfizer
Abbott enhances its position in fast-growing Latin American market
Abbott (NYSE: ABT) has announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding Abbott's presence in fast-growing markets. Under the terms of the agreement, Abbott will acquire the holding company that indirectly owns approximately 73 percent of CFR Pharmaceuticals and will conduct a public cash tender offer for all of the outstanding shares of CFR.
Read more...
http://www.worldpharmanews.com/abbott/2777-abbott-enhances-its-position-in-fast-growing-latin-american-market
MedImmune and Incyte announce collaboration on immuno-oncology combination clinical trial
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation. The Phase I/II oncology study will evaluate the efficacy and safety of MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Incyte's oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360.
Read more...
http://www.worldpharmanews.com/astrazeneca/2776-medimmune-and-incyte-announce-collaboration-on-immuno-oncology-combination-clinical-trial
Boehringer Ingelheim will make detailed clinical trial data available to the scientific community
In order to add to scientific and medical progress, Boehringer Ingelheim is engaged in a program to make clinical study data and other clinical study related documents more widely accessible for approved products or after termination of a drug development program.
Read more...
http://www.worldpharmanews.com/boehringer-ingelheim/2775-boehringer-ingelheim-will-make-detailed-clinical-trial-data-available-to-the-scientific-community
Bayer HealthCare extends access to clinical trial data
Bayer HealthCare will start sharing data from its clinical studies through the internet portal http://www.clinicalstudydatarequest.com. From now on, qualified researchers can request anonymized patient-level data from Bayer HealthCare sponsored clinical studies listed on the website. By joining the portal, Bayer HealthCare is supporting efforts of the European Medicines Agency (EMA) to increase the transparency of data from clinical studies.
Read more...
http://www.worldpharmanews.com/bayer/2774-bayer-healthcare-extends-access-to-clinical-trial-data
Pfizer announcement and AstraZeneca statement
Pfizer wishes to enter into discussions with AstraZeneca regarding a potential combination of the two companies and is "disappointed at the lack of engagement by the AstraZeneca Board". The Board of AstraZeneca notes the announcement made by Pfizer and states that the "announcement contains no new proposal nor substantive new information."
Read more...
http://www.worldpharmanews.com/financial/2773-pfizer-announcement-and-astrazeneca-statement
Scientists find new way to mobilize immune system against viruses
University of British Columbia scientists have uncovered an intricate chain reaction in the body's immune system and have used the knowledge to develop a new treatment against harmful viruses. Viral pandemics, such as the coronavirus that caused the deadly SARS outbreak in 2002, have caused hundreds of deaths in Canada, yet effective anti-viral drugs are rare.
Read more...
http://www.worldpharmanews.com/research/2772-scientists-find-new-way-to-mobilize-immune-system-against-viruses
PharmaNews.eu / Latest News
AstraZeneca and MRC Laboratory of Molecular Biology to launch joint research fund
http://www.pharmanews.eu/astrazeneca/1444-astrazeneca-and-mrc-laboratory-of-molecular-biology-to-launch-joint-research-fund
Shark antibodies inspire optimization of human antibodies
http://www.pharmanews.eu/research-and-development/1442-shark-antibodies-inspire-optimization-of-human-antibodies
New agent may enhance effectiveness of radiotherapy
http://www.pharmanews.eu/research-and-development/1443-new-agent-may-enhance-effectiveness-of-radiotherapy
Atlas shows how genes affect our metabolism
http://www.pharmanews.eu/research-and-development/1440-atlas-shows-how-genes-affect-our-metabolism
CNIO team presents a new strategy to personalise cancer therapies
http://www.pharmanews.eu/research-and-development/1441-cnio-team-presents-a-new-strategy-to-personalise-cancer-therapies
EMA publishes 2013 annual report
http://www.pharmanews.eu/ema/1439-ema-publishes-2013-annual-report
NCI, NCRI and EORTC working group outline risk-assessment approach for biomarker-driven cancer clinical trials
http://www.pharmanews.eu/research-and-development/1438-nci-ncri-and-eortc-working-group-outline-risk-assessment-approach-for-biomarker-driven-cancer-clinical-trials
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.
Read more...
http://www.worldpharmanews.com/financial/2778-astrazeneca-rejects-final-proposal-from-pfizer
Abbott enhances its position in fast-growing Latin American market
Abbott (NYSE: ABT) has announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding Abbott's presence in fast-growing markets. Under the terms of the agreement, Abbott will acquire the holding company that indirectly owns approximately 73 percent of CFR Pharmaceuticals and will conduct a public cash tender offer for all of the outstanding shares of CFR.
Read more...
http://www.worldpharmanews.com/abbott/2777-abbott-enhances-its-position-in-fast-growing-latin-american-market
MedImmune and Incyte announce collaboration on immuno-oncology combination clinical trial
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation. The Phase I/II oncology study will evaluate the efficacy and safety of MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Incyte's oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360.
Read more...
http://www.worldpharmanews.com/astrazeneca/2776-medimmune-and-incyte-announce-collaboration-on-immuno-oncology-combination-clinical-trial
Boehringer Ingelheim will make detailed clinical trial data available to the scientific community
In order to add to scientific and medical progress, Boehringer Ingelheim is engaged in a program to make clinical study data and other clinical study related documents more widely accessible for approved products or after termination of a drug development program.
Read more...
http://www.worldpharmanews.com/boehringer-ingelheim/2775-boehringer-ingelheim-will-make-detailed-clinical-trial-data-available-to-the-scientific-community
Bayer HealthCare extends access to clinical trial data
Bayer HealthCare will start sharing data from its clinical studies through the internet portal http://www.clinicalstudydatarequest.com. From now on, qualified researchers can request anonymized patient-level data from Bayer HealthCare sponsored clinical studies listed on the website. By joining the portal, Bayer HealthCare is supporting efforts of the European Medicines Agency (EMA) to increase the transparency of data from clinical studies.
Read more...
http://www.worldpharmanews.com/bayer/2774-bayer-healthcare-extends-access-to-clinical-trial-data
Pfizer announcement and AstraZeneca statement
Pfizer wishes to enter into discussions with AstraZeneca regarding a potential combination of the two companies and is "disappointed at the lack of engagement by the AstraZeneca Board". The Board of AstraZeneca notes the announcement made by Pfizer and states that the "announcement contains no new proposal nor substantive new information."
Read more...
http://www.worldpharmanews.com/financial/2773-pfizer-announcement-and-astrazeneca-statement
Scientists find new way to mobilize immune system against viruses
University of British Columbia scientists have uncovered an intricate chain reaction in the body's immune system and have used the knowledge to develop a new treatment against harmful viruses. Viral pandemics, such as the coronavirus that caused the deadly SARS outbreak in 2002, have caused hundreds of deaths in Canada, yet effective anti-viral drugs are rare.
Read more...
http://www.worldpharmanews.com/research/2772-scientists-find-new-way-to-mobilize-immune-system-against-viruses
PharmaNews.eu / Latest News
AstraZeneca and MRC Laboratory of Molecular Biology to launch joint research fund
http://www.pharmanews.eu/astrazeneca/1444-astrazeneca-and-mrc-laboratory-of-molecular-biology-to-launch-joint-research-fund
Shark antibodies inspire optimization of human antibodies
http://www.pharmanews.eu/research-and-development/1442-shark-antibodies-inspire-optimization-of-human-antibodies
New agent may enhance effectiveness of radiotherapy
http://www.pharmanews.eu/research-and-development/1443-new-agent-may-enhance-effectiveness-of-radiotherapy
Atlas shows how genes affect our metabolism
http://www.pharmanews.eu/research-and-development/1440-atlas-shows-how-genes-affect-our-metabolism
CNIO team presents a new strategy to personalise cancer therapies
http://www.pharmanews.eu/research-and-development/1441-cnio-team-presents-a-new-strategy-to-personalise-cancer-therapies
EMA publishes 2013 annual report
http://www.pharmanews.eu/ema/1439-ema-publishes-2013-annual-report
NCI, NCRI and EORTC working group outline risk-assessment approach for biomarker-driven cancer clinical trials
http://www.pharmanews.eu/research-and-development/1438-nci-ncri-and-eortc-working-group-outline-risk-assessment-approach-for-biomarker-driven-cancer-clinical-trials
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages